BIO INVENTION AS
987594152ActiveClinical-stage company developing novel immuno-oncology antibody therapeutics for cancer.
Clinical-Stage Biotechnology Companybioinvent.com
Overview
- Unknown
- Employees
- 22K NOK
- Revenue
- 2004
- Founded
Key Decision Makers
Mona Welschof
Clinical Operations
@bioinvent.com
Björn Frendéus
CSO
@bioinvent.com
Sylvie Ryckebusch
Chief Business Officer
@bioinvent.com
Linda Mårtensson
Employee
@bioinvent.com
Description
BioInvent is a clinical-stage biotechnology company focused on discovering and developing innovative antibody therapeutics for cancer treatment. The core of their work lies in leveraging deep expertise in immunology, cancer biology, and antibody biology to generate novel immuno-oncology drug candida...
Alligator Bioscience AB